Patients

FF Fangqiu Fu
CD Chaoqiang Deng
WS Wenrui Sun
QZ Qiang Zheng
YJ Yan Jin
YL Yuan Li
YZ Yang Zhang
HC Haiquan Chen
ask Ask a question
Favorite

This study was approved by the Institutional Review Board of Fudan University Shanghai Cancer Center (FUSCC) (IRB#090977-1) under the approval number of 2008223-9, and it was carried out in a consecutive NSCLC cohort who received surgical resection or biopsy at the Department of Thoracic Surgery and PD-L1 testing at the Department of Pathology in Fudan Shanghai Cancer Center from September 2017 to April 2021. The following clinicopathological factors were prospectively collected: age, sex, smoking history, sample type, tumor histology, TNM stage, tumor spread thorough air space (STAS), and common gene alterations. The distinguishment of multifocal or metastatic lung cancers was based on the criteria released by IASLC Lung Cancer Staging Project [6].

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A